Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Norditropin SimpleXx approved in Japan

March 22, 2000

New integrin alphav receptor antagonists patented by Merck

March 21, 2000

Potential for drug interactions of Sch-58235 evaluated in humans

March 20, 2000

First human data reported for GI-262570 at recent scientific forum

March 20, 2000

German launch for Mifegyne announced

March 20, 2000

Calcilytic compounds described by SB for use in disorders of bone or mineral homeostasis

March 20, 2000

SmithKline Beecham's Avandia receives positive opinion from CPMP

March 17, 2000

Drugs for hyperlipidemia in development at Nippon Soda

March 17, 2000

Insmed and Taisho sign letter of intent for INS-1

March 17, 2000

Nicostatin effective for increasing "good" cholesterol, lowering "bad" cholesterol

March 16, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...